Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes: a tipping point in neurodegenerative diseases
José A. Santiago, M. Ganesh Karthikeyan, Madison Lackey, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1029-1044
Open Access | Times Cited: 20

Showing 20 citing articles:

Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 3
Risk of Glaucoma in Non-Diabetic Patients using a Glucagon Like Peptide-1 Receptor Agonist
Pranav Vasu, Emily Dorairaj, Robert N. Weinreb, et al.
Ophthalmology (2025)
Closed Access | Times Cited: 3
Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
Yiyi Zhu, Alexei Verkhratsky, Hui Chen, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 2
Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
Xiahao Ding, Yin Li, Lin Zhang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4583-4593
Open Access | Times Cited: 14
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Chien‐Tai Hong, Jia‐Hung Chen, Chaur‐Jong Hu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 11
Role of MARK2 in the nervous system and cancer
Yining Lei, Ruyi Zhang, Fei Cai
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 497-506
Closed Access | Times Cited: 4
The potential role of gut microbiota-derived metabolites as regulators of metabolic syndrome-associated mitochondrial and endolysosomal dysfunction in Alzheimer’s disease
Young Hyun Jung, Chang Woo Chae, Ho Jae Han
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 8, pp. 1691-1702
Open Access | Times Cited: 4
Diabetes Mellitus Impairs Blood‐Brain Barrier Integrality and Microglial Reactivity
Shaojun Liu, Jie Hao, Tingting Yu, et al.
Journal of Biophotonics (2025)
Closed Access
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
The Neurobiology of Comorbidities
Mojtaba Oraki Kohshour, Alba Navarro-Flores, Monika Budde, et al.
(2025), pp. 89-125
Closed Access
Analysis of Molecular Aspects of Periodontitis as a Risk Factor for Neurodegenerative Diseases: A Single-Center 10-Year Retrospective Cohort Study
Amr Sayed Ghanem, Marianna Móré, Attila Nagy
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2382-2382
Open Access
Lifestyle Interventions and Innovative Approaches for the Management of Neurodegenerative Disorders in Older Adults—State-Of-The-Art and Future Directions
Iuliana Popescu, Manon Lenain, Erika Rovini, et al.
American Journal of Lifestyle Medicine (2025)
Closed Access
Pyruvate kinase deficiency links metabolic perturbations to neurodegeneration and axonal protection
Thomas J. Waller, Catherine A. Collins, Monica Dus
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study
Yingjie Zhao, Fei Lu, Yongtao Duan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111128-111128
Closed Access | Times Cited: 3
Clinical and Sociodemographic Factors Related to Amyotrophic Lateral Sclerosis in Spain: A Pilot Study
Belén Proaño, María Cuerda‐Ballester, Noelia Daroqui-Pajares, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5800-5800
Open Access | Times Cited: 1
Abnormal eye movements: relationship with clinical symptoms and predictive value for Alzheimer’s disease
Jing Qi, Teng-hong Lian, Peng Guo, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Insight into the Effect of Methylglyoxal on the Conformation, Function, and Aggregation Propensity of α‐Synuclein
Laura Mariño, Ana Belén Uceda, Francisco Leal, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 36
Open Access
Notoginsenoside R1, a novel natural PPARγ agonist, attenuates cognitive deficits in a mouse model of diabetic Alzheimer’s disease through enhancing GLUT4-dependent neuronal glucose uptake
Zongyang Li, Ping Cui, Rui Su, et al.
Research Square (Research Square) (2024)
Closed Access
Mitochondrial Transfer in the Neurovascular Unit, Not Only for Energy Rescue: A Systematic Review
Daqiang Zhou, Sibo Yang, Jiehong Wu, et al.
Aging and Disease (2024)
Open Access
Metabolic Syndrome and the Risk of Alzheimer’s Disease: A Meta-Analysis
Yi Feng, Lili Cheng, Weiying Zhou, et al.
Metabolic Syndrome and Related Disorders (2024)
Closed Access
Page 1

Scroll to top